Role of RBMS3 novel potential regulator of the EMT phenomenon in physiological and pathological processes

T Górnicki, J Lambrinow, M Mrozowska… - International journal of …, 2022 - mdpi.com
RNA-binding protein 3 (RBMS3) plays a significant role in embryonic development and the
pathogenesis of many diseases, especially cancer initiation and progression. The multiple …

RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA

CJ Block, AV Mitchell, L Wu, J Glassbrook, D Craig… - Oncogene, 2021 - nature.com
The epithelial-to-mesenchymal transition (EMT) has been recognized as a driving force for
tumor progression in breast cancer. Recently, our group identified the RNA Binding Motif …

[HTML][HTML] RNA-Binding Proteins in Breast Cancer: Biological Implications and Therapeutic Opportunities

S Wang, H Sun, G Chen, C Wu, B Sun, J Lin… - Critical Reviews in …, 2024 - Elsevier
RNA-binding proteins (RBPs) refer to a class of proteins that participate in alternative
splicing, RNA stability, polyadenylation, localization and translation of RNAs, thus regulating …

Identifying critical states of complex diseases by single-sample Jensen-Shannon divergence

J Yan, P Li, R Gao, Y Li, L Chen - Frontiers in oncology, 2021 - frontiersin.org
Motivation The evolution of complex diseases can be modeled as a time-dependent
nonlinear dynamic system, and its progression can be divided into three states, ie, the …

[HTML][HTML] Long non-coding RNAs as potential biomarkers or therapeutic targets in gastric cancer

N Askari, BS Esfahani, S Parvizpour… - … and Hepatology from …, 2023 - ncbi.nlm.nih.gov
Aim: This study aimed to find lncRNAs and mRNAs that were expressed differently by
combining microarray datasets from different studies. This was done to find important target …

[HTML][HTML] RBMS3, a downstream target of AMPK, Exerts Inhibitory Effects on Invasion and Metastasis of Lung Cancer

SL Lv, X Zhou, Y Li, L Luo, DQ Huang - Journal of Cancer, 2023 - ncbi.nlm.nih.gov
Background: Lung cancer is a highly malignant disease, primarily due to its propensity for
metastasis. AMP-activated protein kinase (AMPK), the principal downstream effector of Liver …

RBMS3-induced circHECTD1 encoded a novel protein to suppress the vasculogenic mimicry formation in glioblastoma multiforme

X Ruan, Y Liu, P Wang, L Liu, T Ma, Y Xue… - Cell Death & …, 2023 - nature.com
Glioblastoma multiforme (GBM) is a highly vascularized malignant cancer of the central
nervous system, and the presence of vasculogenic mimicry (VM) severely limits the …

Expression of RBMS3 in breast cancer progression

T Górnicki, J Lambrinow, M Mrozowska… - International Journal of …, 2023 - mdpi.com
The aim of the study was to evaluate the localization and intensity of RNA-binding motif
single-stranded-interacting protein 3 (RBMS3) expression in clinical material using …

Tumor suppressor function of RBMS3 overexpression in EOC associated with immune cell infiltration

T Yin, Y Zhang, Y Zhao, X Zhang, S Han, Y Wang… - Heliyon, 2024 - cell.com
Objectives Epithelial ovarian cancer (EOC) is considered to be a prevalent female
malignancy with both high incidence and mortality. It is reported that RNA-binding protein 3 …

Serum exosomal miR‐3662 down‐regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells

X Li, X Chu, H Wang, L Xiang… - Chemical Biology & Drug …, 2024 - Wiley Online Library
Breast cancer (BC) is a prevalent malignancy among women worldwide. As an anticancer
drug of pyrimidine nucleoside analogs, gemcitabine can be used to treat BC, but its clinical …